\n\nPatients/methods Twenty patients with known coronary artery disease receiving 75mg/day clopidogrel were recruited and given 150 mg/day clopidogrel for 30 days, then returned to 75 mg/day for an additional 30 days. Platelet function was assessed through light-transmittance aggregometry (LTA) and the VerifyNow P2Y12 assay at baseline, 30 days, and 60 days.\n\nResults Mean platelet inhibition was significantly improved with the increased maintenance dose when measured by the VerifyNow P2Y12 assay (P2Y12 reaction units: 191 +/- 15 vs. 158 +/- 17, P=0.013), but not when measured by LTA (LTA-adenosine diphosphate 5: 40 +/- 3 vs 36 +/- 3, P=0.11; LTA-adenosine diphosphate
20: 50 +/- 3 vs. 47 +/- 3, P=0.23). However, only 50% of individual patients experienced improved platelet inhibition, as measured
by the VerifyNow P2Y12 assay, when treated with the increased maintenance dose. Furthermore, selleck screening library poor baseline platelet response did not predict improved responsiveness at the increased dose.\n\nConclusion Despite changing the population’s mean antiplatelet response, an increased maintenance dose of clopidogrel did not improve antiplatelet response in a substantial number of patients; nor did baseline platelet function predict response to a higher maintenance dose. Coron Artery Dis 20:207-213 (C) 2009 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.”
“Cerebrospinal fluid (CSF) spaces include ventricles and cerebral and spinal subarachnoid spaces. CSF motion is a combined effect of CSF production rate and 432 superimposed Stem Cell Compound Library concentration cardiac pulsations. Knowledge of CSF dynamics has benefited considerably from the development of phase-contrast (PC) MRI. There are several disorders such as communicating and non-communicating hydrocephalus,
Chiari malformation, syringomyelic cyst and arachnoid cyst that can change the CSF dynamics. The aims of this pictorial review are to outline the PC MRI technique, CSF physiology and cerebrospinal space anatomy, to describe a group of congenital and acquired disorders that can alter the CSF dynamics, and to assess the use of PC MRI in the assessment of various central nervous system abnormalities.”
“Objective: Mitral BLZ945 manufacturer regurgitation (MR) due to commissural prolapse/flail can be corrected by suturing the margins of the anterior and posterior leaflets in the commissural area (commissural closure). The long-term results of this type of repair are unknown. Our aim was to assess the clinical and echocardiographic outcomes of this technique up to 15 years after surgery. Methods: From 1997 to 2007, 125 patients (age, 56.8 +/- 15.7 years; left ventricular ejection fraction, 58.1% +/- 7.1%) with MR due to pure commissural prolapse/flail of 1 or both leaflets underwent commissural closure combined with annuloplasty. The etiology of the disease was degenerative in 88.8% and endocarditis in 11.2%. The commissural region involved was posteromedial in 96 patients (76.8%) and anterolateral in 29 (23.